Serafín Delgado

501 total citations
12 papers, 334 citations indexed

About

Serafín Delgado is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Serafín Delgado has authored 12 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Pathology and Forensic Medicine and 4 papers in Surgery. Recurrent topics in Serafín Delgado's work include Lymphoma Diagnosis and Treatment (7 papers), CNS Lymphoma Diagnosis and Treatment (4 papers) and Colorectal and Anal Carcinomas (4 papers). Serafín Delgado is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), CNS Lymphoma Diagnosis and Treatment (4 papers) and Colorectal and Anal Carcinomas (4 papers). Serafín Delgado collaborates with scholars based in Mexico and United States. Serafín Delgado's co-authors include Agustín Avilés, M. Jesús Nambo, Natividad Neri, Sergio Cleto, Judith Huerta‐Guzmán, José C. Díaz‐Maqueo, Pedro Luna‐Pérez, Sonia Labastida, Alejandra Talavera and Belém Trejo‐Valdivia and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, The American Journal of Surgery and Annals of Surgical Oncology.

In The Last Decade

Serafín Delgado

12 papers receiving 327 citations

Peers

Serafín Delgado
Greg Hapgood Australia
C Ghandour France
R. Tubbs United States
Jozef Malysz United States
T Anderson United States
Greg Hapgood Australia
Serafín Delgado
Citations per year, relative to Serafín Delgado Serafín Delgado (= 1×) peers Greg Hapgood

Countries citing papers authored by Serafín Delgado

Since Specialization
Citations

This map shows the geographic impact of Serafín Delgado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serafín Delgado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serafín Delgado more than expected).

Fields of papers citing papers by Serafín Delgado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serafín Delgado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serafín Delgado. The network helps show where Serafín Delgado may publish in the future.

Co-authorship network of co-authors of Serafín Delgado

This figure shows the co-authorship network connecting the top 25 collaborators of Serafín Delgado. A scholar is included among the top collaborators of Serafín Delgado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serafín Delgado. Serafín Delgado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Avilés, Agustín, et al.. (2005). Primary Breast Lymphoma: Results of a Controlled Clinical Trial. Oncology. 69(3). 256–260. 107 indexed citations
2.
Avilés, Agustín, Natividad Neri, Serafín Delgado, et al.. (2005). Residual Disease After Chemotherapy in Aggressive Malignant Lymphoma: The Role of Radiotherapy. Medical Oncology. 22(4). 383–388. 22 indexed citations
3.
Avilés, Agustín, et al.. (2002). Combined therapy in advanced stages (III and IV) of follicular lymphoma increases the possibility of cure: results of a large controlled clinical trial. European Journal Of Haematology. 68(3). 144–149. 15 indexed citations
4.
Luna‐Pérez, Pedro, et al.. (1999). Prognostic Factors in Patients with Locally Advanced Rectal Adenocarcinoma Treated with Preoperative Radiotherapy and Surgery. World Journal of Surgery. 23(10). 1069–1075. 21 indexed citations
5.
Avilés, Agustín, et al.. (1999). Adjuvant Radiotherapy to Initial Bulky Disease in Patients with Advanced Stage Hodgkin's Disease. Hematology. 4(6). 479–485. 6 indexed citations
6.
Luna‐Pérez, Pedro, et al.. (1999). Inguinal lymph node metastases from rectal adenocarcinoma. Journal of Surgical Oncology. 70(3). 177–180. 1 indexed citations
7.
Avilés, Agustín, et al.. (1996). IMPROVED OUTCOME IN SOLITARY BONE PLASMACYTOMATA WITH COMBINED THERAPY. Hematological Oncology. 14(3). 111–117. 59 indexed citations
8.
Avilés, Agustin, Renaldo Guzmán, Serafín Delgado, et al.. (1996). Intensive brief chemotherapy with hematopoietic growth factors as hematological support and adjuvant radiotherapy improve the prognosis in aggressive malignant lymphoma. American Journal of Hematology. 52(4). 275–280. 10 indexed citations
9.
Luna‐Pérez, Pedro, et al.. (1996). Patterns of recurrence following pelvic exenteration and external radiotherapy for locally advanced primary rectal adenocarcinoma. Annals of Surgical Oncology. 3(6). 526–533. 17 indexed citations
10.
Avilés, Agustín, et al.. (1994). Adjuvant radiotherapy to sites of previous bulky disease in patients stage iv diffuse large cell lymphoma. International Journal of Radiation Oncology*Biology*Physics. 30(4). 799–803. 61 indexed citations
11.
Avilés, Agustin, et al.. (1994). Combined therapy for angioimmunoproliferative lesions. European Journal of Cancer Part B Oral Oncology. 30(5). 302–304. 6 indexed citations
12.
Luna‐Pérez, Pedro, et al.. (1990). Usefulness of frozen-section examination in resected mid-rectal cancer after preoperative radiation. The American Journal of Surgery. 159(6). 582–584. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026